Salbutamol sulfate
CAS number： 51022-70-9
Molecular formula： 2(C13H21NO3).H2O4S
molecular weight： 576.70
Chemical structure：
Producers shown on SFDA
(Record date:08/10/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
Yunpeng Pharmaceutical Group Co., Ltd. | GMP | Valid till October 2023 |
Suzhou Homesun Pharmaceutical Co., Ltd. | GMP | Valid till August 2018 |
Changzhou Yabang Pharmaceutical Co., Ltd. | GMP | Valid till June 2019 |
Jewim Pharmaceutical (Shandong) Co., Ltd. | GMP | Valid till December 2024 |
Producers shown on EP
(Quoted from EP website；record date:12/10/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Salbutamol sulfate | Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE | R1-CEP 1997-004 - Rev 04 | 23/06/2010 | Valid | / | Chemical |
| Salbutamol sulfate | Lusochimica S.p.A. Lomagna IT | R1-CEP 2005-235 - Rev 01 | 29/07/2016FDC Limited Mumbai IN | Valid | / | Chemical |
| Salbutamol sulfate | FDC Limited Mumbai IN | R0-CEP 2015-212 - Rev 00 | 08/06/2017 | Valid | / | Chemical |
| Salbutamol sulfate | Neuland Laboratories Limited Hyderabad IN | R1-CEP 2000-143 - Rev 06 | 23/06/2017 | Valid | / | Chemical |
| Salbutamol sulfate Code 6885 | CIPLA LIMITED Mumbai IN | R1-CEP 2011-314 - Rev 01 | 08/12/2017 | Valid | / | Chemical |
| Salbutamol sulfate | CIPLA LIMITED Mumbai IN | R1-CEP 2005-080 - Rev 03 | 30/05/2018 | Valid | / | Chemical |
| Salbutamol sulfate Micronised | MELODY HEALTHCARE PVT. LTD. Boisar IN | R0-CEP 2020-063 - Rev 00 | 21/10/2020 | Valid | / | Chemical |
| Salbutamol sulfate | SUPRIYA LIFESCIENCE LTD. Mumbai IN | R0-CEP 2019-037 - Rev 00 | 09/07/2021 | Valid | / | Chemical |
| Salbutamol sulfate | MELODY HEALTHCARE PVT. LTD. Boisar IN | R1-CEP 2014-193 - Rev 00 | 09/08/2021 | Valid | / | Chemical |
| Salbutamol sulfate | TEVA PHARMACEUTICAL INDUSTRIES LTD. Petach Tikva IL | R0-CEP 2020-100 - Rev 00 | 14/09/2021 | Valid | / | Chemical |
Producer:Yunpeng Pharmaceutical Group Co., Ltd. was established in 1998. It mainly produces and develops tablets, capsules, granules and injections, all of which have passed GMP certification. It has 9 subsidiaries and 1 branch with total assets of 1.2 billion yuan. At present, norfloxacin, indomethacin and mexiletine hydrochloride have been registered in India, and indomethacin has been registered in Russia, Mexico, Egypt, South Korea and other places. In Japan, mexiletine hydrochloride and vitamin U have also been reviewed by JDMF.
Staff size:300-399 persons
Registered capital:RMB 200 million
Producer:Suzhou Homesun Pharmaceutical Co., Ltd.was established on April 17, 2009, production address: Jiangsu Taicang Port Development Zone, petrochemical zone GCL Road on the 12th, registered capital of 98 million yuan, 2.3 million yuan in fixed assets, covers an area of 4.3 million square meters, construction area of 2.5 million square meters.
Company's main products include pharmaceutical intermediates, pharmaceutical raw materials (including sterile APIs), frozen dried powder injection, small volume injection, oral solid dosage forms (tablets and capsules) and inhalation solution. Currently has 17 APIs and small capacity injection workshop, tablets, hard capsule agent through the national GMP certification, with an annual output of: 350 tons of raw material medicine (fine baked package), 1 billion ampoules of small volume injections, 15 million tablets, 1 million capsules agent, product coverage of antitumor, antiviral, central nervous, anti infective, cardiovascular, digestive, antipyretic analgesic class.
Staff size:About 150 persons
Registered capital:RMB 98 million
Producer:Changzhou Yabang Pharmaceutical Co., Ltd., established in October 2002, is located at No. 6, Liangchang East Road, Jintan Economic Development Zone, Changzhou City, Jiangsu Province, with a registered capital of 70 million yuan. Its business scope is the production and sales of chemical APIs. It is a subsidiary controlled by Jiangsu Yabang Pharmaceutical Group Co., Ltd.
The company covers an area of 80000 square meters, a construction area of 14000 square meters and a total investment of more than 100 million. It has 6 fine baking bag production lines, 5 synthesis workshops, 1 hydrogenation workshop, 1 testing center and 1 R & D center that meet the requirements of GMP, a set of sewage treatment devices and environmental protection facilities. The greening area is more than 40%, forming a professional company of 500 t / a API and pharmaceutical intermediates.
Staff size:200-299 persons
Registered capital:RMB 70 million
Producer:Jewim Pharmaceutical (Shandong) Co., Ltd. is located in an area of 200 mu, All the dosage forms of the company's listed products have passed the inspection and certification of the China food and drug administration, and the quality system has repeatedly passed the GMP certification of the Australian drug administration (TGA). The products are exported to more than 50 countries such as the United States, Australia and New Zealand.
Staff size:900-999 persons
Registered capital:RMB 100 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE